CCO Independent Conference Coverage

2008 Conference on Retroviruses and Opportunistic Infections

• Clinical Update on First-Line Antiretroviral Therapy
• Management of Treatment-Experienced Patients
• Antiretroviral Drug Resistance
• Metabolic Complications and Adverse Events
• Hepatitis and Opportunistic Coinfections

2007 Interscience Conference on Antimicrobial Agents and Chemotherapy

• HIV Highlights From ICAAC

2007 European AIDS Conference

4th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention

• First-Line Therapy and Switch Strategies
• Resistance and Management of Treatment-Experienced Patients
• Investigational Antiretrovirals
• Clinical Complications in HIV-Infected Patients
• Treatment Issues in Resource-Limited Settings
• Biomedical Approaches to Preventing HIV Transmission
• Metabolic Issues: A Slide Based Review
• Update on Metabolic Complications and Adverse Effects in HIV

2007 International Workshop on Clinical Pharmacology of HIV Therapy

• Update on HIV Pharmacology From the 2007 Budapest Meeting

2007 International HIV Drug Resistance Workshop

• Conference Report

2007 Conference on Retroviruses and Opportunistic Infections

• First-Line Therapy and Switch Strategies
• Resistance and Management of Treatment-Experienced Patients
• Investigational Antiretrovirals
• Current Issues in Antiretroviral Therapy
• Metabolic Complications and Adverse Events
• Hepatitis and Opportunistic Diseases

2006 International Congress on Drug Therapy in HIV Infection

• Conference Report
• Slideset Module

2006 Annual Meeting of the Infectious Disease Society of America

• Conference Report

2006 Interscience Conference on Antimicrobial Agents and Chemotherapy

• Clinical Studies of Antiretroviral Therapy
• Clinical Complications and Coinfections in HIV-Infected Patients

2006 International HIV Drug Resistance Workshop

• Coverage of the 2006 International HIV Drug Resistance Workshop

2006 International AIDS Conference

• First-Line Therapy and Switch Strategies
• Resistance and Management of Treatment-Experienced Patients
• New Agents and Insights from Basic Science
• Clinical Pharmacology and Adverse Events
• Metabolic Complications and Lipodystrophy
• Hepatitis and Opportunistic Coinfections
• Global Epidemiology and Management Issues in Resource-Limited Settings
• Mother-to-Child Transmission and Management of Pediatric HIV Infection

Coverage of the 2006 International Workshop on Clinical Pharmacology of HIV Therapy

• Conference Report

2006 European HIV Drug Resistance Workshop

• Conference Report

2006 Conference on Retroviruses and Opportunistic Infections

• First-Line Therapy and Switch Strategies
• Resistance and Management of Treatment-Experienced Patients
• Investigational Antiretrovirals
• Clinical Pharmacology and Adverse Events
• Metabolic Complications and Lipodystrophy
• Hepatitis and Opportunistic Coinfections
• Transmission, Prevention, and Management Issues in Resource-Limited Settings

2005 Interscience Conference on Antimicrobial Agents and Chemotherapy

• Clinical Studies of Antiretroviral Therapy
• Clinical Complications and Coinfections in HIV-Infected Patients

2005 International Workshop on Targeting HIV Entry

• Coverage of the 1st International Workshop on Targeting HIV Entry

2005 International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV and the 2005 European AIDS Clinical Society Conference

• Dublin: HIV/AIDS Update

2005 European AIDS Conference

• Clinical Studies of Antiretroviral Therapy
• Clinical Complications and Coinfections in HIV-Infected Patients

2005 International Workshop on Adverse Drug Reactions And Lipodystrophy in HIV

• Coverage of the 7th International Workshop on Adverse Drug Reactions And Lipodystrophy in HIV

2005 International AIDS Society Conference on HIV Pathogenesis and Treatment

• First-line Therapy and Switch Strategies
• Resistance and Management of Treatment-Experienced Patients
• New Agents and Insights from Basic Science
• Pharmacology & Adverse Events
• Hepatitis Coinfection and Opportunistic Infections
• Metabolic Complications & Lipodystrophy
• Mother-to-Child Transmission and Management Issues in Resource-Poor Settings

2005 International HIV Drug Resistance Workshop

• New Data on Antiretroviral Resistance

2005 International Workshop on Clinical Pharmacology of HIV Therapy

• New Data on HIV Pharmacology

2005 Conference on Retroviruses and Opportunistic Infections

• Management of Treatment-Naive Patients
• Resistance and Management of Experienced Patients
• Investigational Antiretroviral Agents
• Pharmacology and Adverse Drug Effects
• Hepatitis Coinfection and Opportunistic Infections
• Metabolic Complications and Lipodystrophy

2004 International Workshop on HIV and Hepatitis Coinfection

2004 Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

• Clinical Studies of Antiretroviral Therapy
• Clinical Complications and Coinfections in HIV-Infected Patients

2004 International Workshop on Adverse Drug Reactions And Lipodystrophy in HIV

• Coverage of the 6th International Workshop on Adverse Drug Reactions And Lipodystrophy in HIV

2004 International Congress on Drug Therapy in HIV Infection

• Coverage of the 7th International Congress on Drug Therapy in HIV Infection

2004 International AIDS Conference

• Initial Therapy, Treatment Interruption, and Induction/Maintenance
• Resistance, New Agents, and Management of Antiretroviral-Experienced Patients
• Metabolic and Morphologic Complications
• Hepatitis Coinfection and Opportunistic Diseases
• HIV Pharmacology and Adverse Effects of Therapy

2004 International HIV Drug Resistance Workshop

• Coverage of the XIII International HIV Drug Resistance Workshop

2004 International Workshop on Clinical Pharmacology of HIV Therapy

• Coverage of the 5th International Workshop on Clinical Pharmacology of HIV Therapy

2004 Conference on Retroviruses and Opportunistic Infections

• Management of Treatment-Naive Patients
• Pharmacology and Adverse Drug Effects
• Hepatitis Coinfection and Opportunistic Infections
• Resistance, Salvage Therapy, and Treatment Strategies
• Metabolic Complications and Lipodystrophy

2003 European AIDS Conference

• Antiretroviral Therapy: Efficacy, Resistance, & Pharmacology
• Complications: Adverse Effects, Coinfections, and OIs

2003 Annual Interscience Conference on Antimicrobial Agents and Chemotherapy Meeting

• Clinical Studies of Antiretroviral Regimens
• Antiretroviral Resistance and Pharmacology
• Hepatitis Coinfection, Metabolic Complications, and OIs

2003 International AIDS Society Conference on HIV Pathogenesis and Treatment

• First-Line Antiretroviral Therapy
• Antiretroviral Resistance & Salvage Therapy
• Antiretroviral Pharmacology and Drug-Drug Interactions
• Opportunistic Infections and Coinfections
• Metabolic Complications and Lipodystrophy
• Clinical Implications of Studies of HIV Pathogenesis

2003 International Conference on Malignancies in AIDS and Other Immunodeficiencies

• HIV-Related Multicentric Castleman's Disease
• Optimal Therapy for Systemic AIDS-Related Lymphoma
• Hepatitis C Infection and the Development of B-Cell Non-Hodgkin's Lymphoma
• Concise Summary

2003 Conference on Retroviruses and Opportunistic Infections

• First-Line Antiretroviral Therapy
• Antiretroviral Resistance, Treatment Interruptions, & Salvage Therapy
• Investigational Antiretrovirals
• Pharmacology and Drug-drug Interactions
• Lipodystrophy and Adverse Effects of Therapy
• Opportunistic Infections and Coinfections